메뉴 건너뛰기




Volumn 16, Issue 1, 2016, Pages

Effects of simvastatin, rosuvastatin and pravastatin on soluble fms-like tyrosine kinase 1 (sFlt-1) and soluble endoglin (sENG) secretion from human umbilical vein endothelial cells, primary trophoblast cells and placenta

Author keywords

Preeclampsia; Pregnancy; SFlt 1; Soluble endoglin; Statins

Indexed keywords

ENDOGLIN; HEME OXYGENASE 1; MESSENGER RNA; PRAVASTATIN; PROTEIN TYROSINE KINASE; ROSUVASTATIN; SIMVASTATIN; SOLUBLE FMS LIKE TYROSINE KINASE 1; UNCLASSIFIED DRUG; ENG PROTEIN, HUMAN; FLT1 PROTEIN, HUMAN; HMOX1 PROTEIN, HUMAN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PLACENTA PROTEIN; VASCULOTROPIN RECEPTOR 1;

EID: 84978091926     PISSN: None     EISSN: 14712393     Source Type: Journal    
DOI: 10.1186/s12884-016-0902-3     Document Type: Article
Times cited : (52)

References (32)
  • 3
    • 20444409135 scopus 로고    scopus 로고
    • Latest advances in understanding preeclampsia
    • Redman CW, Sargent IL. Latest advances in understanding preeclampsia. Science. 2005;308(5728):1592-4.
    • (2005) Science , vol.308 , Issue.5728 , pp. 1592-1594
    • Redman, C.W.1    Sargent, I.L.2
  • 5
    • 79959507759 scopus 로고    scopus 로고
    • Preeclampsia, a disease of the maternal endothelium: the role of antiangiogenic factors and implications for later cardiovascular disease
    • Powe CE, Levine RJ, Karumanchi SA. Preeclampsia, a disease of the maternal endothelium: the role of antiangiogenic factors and implications for later cardiovascular disease. Circulation. 2011;123(24):2856-69.
    • (2011) Circulation , vol.123 , Issue.24 , pp. 2856-2869
    • Powe, C.E.1    Levine, R.J.2    Karumanchi, S.A.3
  • 7
    • 84905117846 scopus 로고    scopus 로고
    • Pre-eclampsia part 1: current understanding of its pathophysiology
    • Chaiworapongsa T, Chaemsaithong P, Yeo L, Romero R. Pre-eclampsia part 1: current understanding of its pathophysiology. Nat Rev Nephrol. 2014;10(8):466-80.
    • (2014) Nat Rev Nephrol , vol.10 , Issue.8 , pp. 466-480
    • Chaiworapongsa, T.1    Chaemsaithong, P.2    Yeo, L.3    Romero, R.4
  • 11
    • 77954040082 scopus 로고    scopus 로고
    • Using pravastatin to improve the vascular reactivity in a mouse model of soluble fms-like tyrosine kinase-1-induced preeclampsia
    • Costantine MM, Tamayo E, Lu F, Bytautiene E, Longo M, Hankins GD, Saade GR. Using pravastatin to improve the vascular reactivity in a mouse model of soluble fms-like tyrosine kinase-1-induced preeclampsia. Obstet Gynecol. 2010;116(1):114-20.
    • (2010) Obstet Gynecol , vol.116 , Issue.1 , pp. 114-120
    • Costantine, M.M.1    Tamayo, E.2    Lu, F.3    Bytautiene, E.4    Longo, M.5    Hankins, G.D.6    Saade, G.R.7
  • 12
    • 84855161062 scopus 로고    scopus 로고
    • Effects of pravastatin on mediators of vascular function in a mouse model of soluble Fms-like tyrosine kinase-1-induced preeclampsia
    • Fox KA, Longo M, Tamayo E, Kechichian T, Bytautiene E, Hankins GD, Saade GR, Costantine MM. Effects of pravastatin on mediators of vascular function in a mouse model of soluble Fms-like tyrosine kinase-1-induced preeclampsia. Am J Obstet Gynecol. 2011;205(4):366. e361-365.
    • (2011) Am J Obstet Gynecol , vol.205 , Issue.4 , pp. 366
    • Fox, K.A.1    Longo, M.2    Tamayo, E.3    Kechichian, T.4    Bytautiene, E.5    Hankins, G.D.6    Saade, G.R.7    Costantine, M.M.8
  • 14
    • 84876676469 scopus 로고    scopus 로고
    • Pravastatin attenuates hypertension, oxidative stress, and angiogenic imbalance in rat model of placental ischemia-induced hypertension
    • Bauer AJ, Banek CT, Needham K, Gillham H, Capoccia S, Regal JF, Gilbert JS. Pravastatin attenuates hypertension, oxidative stress, and angiogenic imbalance in rat model of placental ischemia-induced hypertension. Hypertension. 2013;61(5):1103-10.
    • (2013) Hypertension , vol.61 , Issue.5 , pp. 1103-1110
    • Bauer, A.J.1    Banek, C.T.2    Needham, K.3    Gillham, H.4    Capoccia, S.5    Regal, J.F.6    Gilbert, J.S.7
  • 15
    • 33645895289 scopus 로고    scopus 로고
    • Serum sFlt1 concentration during preeclampsia and mid trimester blood pressure in healthy nulliparous women
    • Levine RJ, Qian C, Maynard SE, Yu KF, Epstein FH, Karumanchi SA. Serum sFlt1 concentration during preeclampsia and mid trimester blood pressure in healthy nulliparous women. Am J Obstet Gynecol. 2006;194(4):1034-41.
    • (2006) Am J Obstet Gynecol , vol.194 , Issue.4 , pp. 1034-1041
    • Levine, R.J.1    Qian, C.2    Maynard, S.E.3    Yu, K.F.4    Epstein, F.H.5    Karumanchi, S.A.6
  • 17
    • 44049091020 scopus 로고    scopus 로고
    • Clinical efficacy and safety of statins in managing cardiovascular risk
    • Kapur NK, Musunuru K. Clinical efficacy and safety of statins in managing cardiovascular risk. Vasc Health Risk Manag. 2008;4(2):341-53.
    • (2008) Vasc Health Risk Manag , vol.4 , Issue.2 , pp. 341-353
    • Kapur, N.K.1    Musunuru, K.2
  • 19
    • 84873828168 scopus 로고    scopus 로고
    • Pravastatin for the prevention of preeclampsia in high-risk pregnant women
    • Costantine MM, Cleary K. Pravastatin for the prevention of preeclampsia in high-risk pregnant women. Obstet Gynecol. 2013;121(2 Pt 1):349-53.
    • (2013) Obstet Gynecol , vol.121 , Issue.2 , pp. 349-353
    • Costantine, M.M.1    Cleary, K.2
  • 20
    • 84906793892 scopus 로고    scopus 로고
    • Soluble endoglin production is upregulated by oxysterols but not quenched by pravastatin in primary placental and endothelial cells
    • Brownfoot FC, Hannan N, Onda K, Tong S, Kaitu'u-Lino T. Soluble endoglin production is upregulated by oxysterols but not quenched by pravastatin in primary placental and endothelial cells. Placenta. 2014;35(9):724-31.
    • (2014) Placenta , vol.35 , Issue.9 , pp. 724-731
    • Brownfoot, F.C.1    Hannan, N.2    Onda, K.3    Tong, S.4    Kaitu'u-Lino, T.5
  • 21
    • 84916878918 scopus 로고    scopus 로고
    • Characterization of protocols for primary trophoblast purification, optimized for functional investigation of sFlt-1 and soluble endoglin
    • Kaitu'u-Lino TJ, Tong S, Beard S, Hastie R, Tuohey L, Brownfoot F, Onda K, Hannan NJ. Characterization of protocols for primary trophoblast purification, optimized for functional investigation of sFlt-1 and soluble endoglin. Pregnancy Hypertens. 2014;4(4):287-95.
    • (2014) Pregnancy Hypertens , vol.4 , Issue.4 , pp. 287-295
    • Kaitu'u-Lino, T.J.1    Tong, S.2    Beard, S.3    Hastie, R.4    Tuohey, L.5    Brownfoot, F.6    Onda, K.7    Hannan, N.J.8
  • 22
    • 84892393113 scopus 로고    scopus 로고
    • Report of the american college of obstetricians and gynecologists' task force on hypertension in pregnancy
    • ACOG. Report of the american college of obstetricians and gynecologists' task force on hypertension in pregnancy. Obstet and gynecol. 2013;122:1122-31.
    • (2013) Obstet and gynecol , vol.122 , pp. 1122-1131
  • 23
    • 80051791363 scopus 로고    scopus 로고
    • Placental expression of a novel primate-specific splice variant of sFlt-1 is upregulated in pregnancies complicated by severe early onset pre-eclampsia
    • Whitehead CL, Palmer KR, Nilsson U, Gao Y, Saglam B, Lappas M, Tong S. Placental expression of a novel primate-specific splice variant of sFlt-1 is upregulated in pregnancies complicated by severe early onset pre-eclampsia. BJOG. 2011;118(10):1268-71.
    • (2011) BJOG , vol.118 , Issue.10 , pp. 1268-1271
    • Whitehead, C.L.1    Palmer, K.R.2    Nilsson, U.3    Gao, Y.4    Saglam, B.5    Lappas, M.6    Tong, S.7
  • 24
    • 79959706617 scopus 로고    scopus 로고
    • Expression of placental FLT1 transcript variants relates to both gestational hypertensive disease and fetal growth
    • Jebbink J, Keijser R, Veenboer G, van der Post J, Ris-Stalpers C, Afink G. Expression of placental FLT1 transcript variants relates to both gestational hypertensive disease and fetal growth. Hypertension. 2011;58(1):70-6.
    • (2011) Hypertension , vol.58 , Issue.1 , pp. 70-76
    • Jebbink, J.1    Keijser, R.2    Veenboer, G.3    Post, J.4    Ris-Stalpers, C.5    Afink, G.6
  • 28
    • 84943383659 scopus 로고    scopus 로고
    • Heme oxygenase-1 is not decreased in preeclamptic placenta and does not negatively regulate placental soluble fms-like tyrosine kinase-1 or soluble endoglin secretion
    • Tong S, Kaitu'u-Lino TJ, Onda K, Beard S, Hastie R, Binder NK, Cluver C, Tuohey L, Whitehead C, Brownfoot F, et al. Heme oxygenase-1 is not decreased in preeclamptic placenta and does not negatively regulate placental soluble fms-like tyrosine kinase-1 or soluble endoglin secretion. Hypertension. 2015;66(5):1073-81.
    • (2015) Hypertension , vol.66 , Issue.5 , pp. 1073-1081
    • Tong, S.1    Kaitu'u-Lino, T.J.2    Onda, K.3    Beard, S.4    Hastie, R.5    Binder, N.K.6    Cluver, C.7    Tuohey, L.8    Whitehead, C.9    Brownfoot, F.10
  • 29
    • 17144429420 scopus 로고    scopus 로고
    • Mechanistic and epidemiologic considerations in the evaluation of adverse birth outcomes following gestational exposure to statins
    • Edison RJ, Muenke M. Mechanistic and epidemiologic considerations in the evaluation of adverse birth outcomes following gestational exposure to statins. Am J Med Genet A. 2004;131(3):287-98.
    • (2004) Am J Med Genet A , vol.131 , Issue.3 , pp. 287-298
    • Edison, R.J.1    Muenke, M.2
  • 30
    • 55549094475 scopus 로고    scopus 로고
    • Maternal exposure to statins and risk for birth defects: a case-series approach
    • Petersen EE, Mitchell AA, Carey JC, Werler MM, Louik C, Rasmussen SA, National Birth Defects Prevention S. Maternal exposure to statins and risk for birth defects: a case-series approach. Am J Med Genet A. 2008;146A(20):2701-5.
    • (2008) Am J Med Genet A , vol.146A , Issue.20 , pp. 2701-2705
    • Petersen, E.E.1    Mitchell, A.A.2    Carey, J.C.3    Werler, M.M.4    Louik, C.5    Rasmussen, S.A.6
  • 32
    • 20044371031 scopus 로고    scopus 로고
    • Statin drugs and congenital anomalies
    • Gibb H, Scialli AR. Statin drugs and congenital anomalies. Am J Med Genet A. 2005;135(2):230-1. author reply 232-234.
    • (2005) Am J Med Genet A , vol.135 , Issue.2 , pp. 230-231
    • Gibb, H.1    Scialli, A.R.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.